论文信息 - Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer - 字舞流文

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

P. LoRusso | E. Ratner | Z. Lin | Y. Lo | J. Moscarelli | S. Giri | Y. Zhu | P. H. Huang | Amy Xiong | Yasmin Korayem | Smith Giri | Jake Moscarelli